Praxis Precision Medicines, Inc. Common Stock Earnings Dividend

Praxis Precision Medicines, Inc. Common Stock’s revenue jumped NaN% since last year same period to $0Mn in the Q2 2026. On a quarterly growth basis, Praxis Precision Medicines, Inc. Common Stock has generated NaN% jump in its revenue since last 3-months.

Praxis Precision Medicines, Inc. Common Stock’s net profit fell -17.7% since last year same period to $-83.72Mn in the Q2 2026. On a quarterly growth basis, Praxis Precision Medicines, Inc. Common Stock has generated 9.55% jump in its net profits since last 3-months.

Praxis Precision Medicines, Inc. Common Stock’s net profit margin jumped NaN% since last year same period to -Inf% in the Q2 2026. On a quarterly growth basis, Praxis Precision Medicines, Inc. Common Stock has generated NaN% jump in its net profit margins since last 3-months.

Praxis Precision Medicines, Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at -3.66 - a -1.67% fall from last quarter’s estimates.

Praxis Precision Medicines, Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at -3.66.

Praxis Precision Medicines, Inc. Common Stock’s earning per share (EPS) jumped 13.29% since last year same period to -2.87 in the Q2 2026. This indicates that the Praxis Precision Medicines, Inc. Common Stock has generated 13.29% annual rate of jump in its earning per share (EPS) in the last 4 quarters.